Generex Biotechnology Corporation announced today that it has been granted a patent by the Mexico National Registry of Patents titled "Aerosol Pharmaceutical Formulation for Pulmonary and Nasal Delivery."

The patent, an extant United States Patent registered by the Company, relates to an improved delivery system for the administration of large-molecule pharmaceuticals which may be administered by means of an aerosol into the mouth for buccal, nasal or pulmonary application.

"We are happy to further enhance the Company's existing drug delivery platform patent portfolio in the region and which emphasizes the broad application of our platform technology," said Rose Perri, the Company's Chief Operating Officer. "We look forward to developing and improving existing aerosol pharmaceutical formulations using the Company's RapidMist(TM) system."

The Company currently holds an aggregate of 72 patents worldwide (19 of which are United States patents) and has an aggregate of 58 patent applications pending in various jurisdictions.

NEWS ARCHIVES

2008

• September
• August
• July
• June
• May
• April
• March

2007

• April
• March
• February
• January

2006

• December
• November
• October
• September
• August
• July
• June
• May
• April
• March
• February
• January

2005

• December
• November
• October
• August
• June
• April
• March
• February

2004

• December

NEWSLETTER SIGNUP